Results
20
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
20 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
RHK | €13.80 | 1.5% | 32.7% | €923.8m | €14.00 | PE20.6x | E7.5% | 1.1% | ||
NXU | €68.70 | 0.1% | 18.0% | €1.2b | €69.64 | PE44.3x | E17.1% | 0.3% | ||
EUZ | €45.28 | -3.0% | 12.6% | €943.9m | €56.50 | PE26.3x | E5.2% | 0.1% | ||
NN6 | €1.34 | -0.4% | -36.5% | €16.9m | n/a | PS4.7x | n/a | 11.2% | ||
M3V | €24.60 | -0.8% | -2.4% | €44.8m | n/a | PE7.8x | n/a | 3.9% | ||
PUS | €16.20 | 0% | -4.7% | €133.6m | n/a | PE26.5x | n/a | 5.4% | ||
AJ91 | €8.00 | 0.6% | -15.3% | €40.6m | n/a | PE16.6x | n/a | 6.3% | ||
HAEK | €10.70 | -0.9% | n/a | €57.5m | n/a | PE5.8x | n/a | 0.4% | ||
UOM | €6.60 | 0% | -37.7% | €5.3m | n/a | PS0.5x | n/a | 1.5% | ||
PHH2 | €224.00 | 4.2% | 9.3% | €795.6m | n/a | PE13.4x | n/a | 3.6% | ||
M12 | €15.55 | -5.5% | 47.4% | €288.5m | €28.00 | PE17.2x | E16.0% | 3.2% | ||
ILM1 | €11.60 | -8.8% | -25.2% | €295.9m | €28.60 | PE23x | E40.9% | n/a | ||
AFX | €47.00 | -13.0% | -53.2% | €4.1b | €61.30 | PE23x | E16.1% | 1.3% | ||
LIK | €306.00 | -6.1% | 14.2% | €89.7m | €641.00 | PE21x | S17.7% | n/a | ||
SBS | €28.25 | -13.1% | -34.3% | €343.4m | €41.00 | PE34.3x | E25.4% | 1.9% | ||
JTH | €12.20 | -1.6% | -10.3% | €24.2m | n/a | PE6.8x | n/a | 4.4% | ||
FME | €45.06 | -0.4% | 18.9% | €13.2b | €41.37 | PE20.1x | E19.3% | 2.6% | ||
FRE | €34.19 | -1.5% | 20.0% | €19.3b | €40.86 | PS0.8x | E37.0% | n/a | ||
MED | €2.42 | -1.6% | -10.4% | €115.0m | €4.75 | PS0.2x | E63.2% | 0% | ||
SYAB | €11.24 | 0% | n/a | €2.5b | n/a | PE27.6x | E-11.4% | 0% |